268 related articles for article (PubMed ID: 28780632)
21. Chaperoning the
Latorre V; Mattenberger F; Geller R
Viruses; 2018 Dec; 10(12):. PubMed ID: 30544818
[TBL] [Abstract][Full Text] [Related]
22. Biomolecular Condensates as Novel Antiviral Targets.
Martin EW; Iserman C; Olety B; Mitrea DM; Klein IA
J Mol Biol; 2024 Feb; 436(4):168380. PubMed ID: 38061626
[TBL] [Abstract][Full Text] [Related]
23. Viral product trafficking to mitochondria, mechanisms and roles in pathogenesis.
Williamson CD; DeBiasi RL; Colberg-Poley AM
Infect Disord Drug Targets; 2012 Feb; 12(1):18-37. PubMed ID: 22034933
[TBL] [Abstract][Full Text] [Related]
24. Targeting nuclear proteins for control of viral replication.
Meng W; Wang XJ; Wang HR
Crit Rev Microbiol; 2019; 45(5-6):495-513. PubMed ID: 30663919
[TBL] [Abstract][Full Text] [Related]
25. Hsp90: a chaperone for HIV-1.
Low JS; Fassati A
Parasitology; 2014 Aug; 141(9):1192-202. PubMed ID: 25004926
[TBL] [Abstract][Full Text] [Related]
26. [The replication cycles of viruses and possibilities of therapeutic modification].
Doerfler W
Arzneimittelforschung; 1988 Mar; 38(3A):442-8. PubMed ID: 3293576
[TBL] [Abstract][Full Text] [Related]
27. Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products.
Zhang M; Zhong J; Xiong Y; Song X; Li C; He Z
Viruses; 2021 Jun; 13(7):. PubMed ID: 34203182
[TBL] [Abstract][Full Text] [Related]
28. [Peptides--a new strategy for combating viral infections].
Kołodziej M; Joniec J; Bartoszcze M; Mirski T; Gryko R
Przegl Epidemiol; 2011; 65(3):477-82. PubMed ID: 22184952
[TBL] [Abstract][Full Text] [Related]
29. Heat shock protein 90 is essential for replication of porcine circovirus type 2 in PK-15 cells.
Liu J; Zhang X; Ma C; You J; Dong M; Yun S; Jiang P
Virus Res; 2016 Sep; 224():29-37. PubMed ID: 27553861
[TBL] [Abstract][Full Text] [Related]
30. Heat shock protein 90 from neglected protozoan parasites.
Roy N; Nageshan RK; Ranade S; Tatu U
Biochim Biophys Acta; 2012 Mar; 1823(3):707-11. PubMed ID: 22198098
[TBL] [Abstract][Full Text] [Related]
31. Antiviral Strategies Based on Lethal Mutagenesis and Error Threshold.
Perales C; Domingo E
Curr Top Microbiol Immunol; 2016; 392():323-39. PubMed ID: 26294225
[TBL] [Abstract][Full Text] [Related]
32. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits.
Naito T; Momose F; Kawaguchi A; Nagata K
J Virol; 2007 Feb; 81(3):1339-49. PubMed ID: 17121807
[TBL] [Abstract][Full Text] [Related]
33. New horizons for antiviral drug discovery from virus-host protein interaction networks.
de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912
[TBL] [Abstract][Full Text] [Related]
34. The multifarious roles of heterogeneous ribonucleoprotein A1 in viral infections.
Kaur R; Lal SK
Rev Med Virol; 2020 Mar; 30(2):e2097. PubMed ID: 31989716
[TBL] [Abstract][Full Text] [Related]
35. Heat shock proteins and virus replication: hsp70s as mediators of the antiviral effects of prostaglandins.
Santoro MG
Experientia; 1994 Nov; 50(11-12):1039-47. PubMed ID: 7988663
[TBL] [Abstract][Full Text] [Related]
36. Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection.
Fraternale A; Zara C; De Angelis M; Nencioni L; Palamara AT; Retini M; Di Mambro T; Magnani M; Crinelli R
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808471
[TBL] [Abstract][Full Text] [Related]
37. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
38. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.
Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA
Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774
[TBL] [Abstract][Full Text] [Related]
39. Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance.
Ma C; Li F; Musharrafieh RG; Wang J
Antiviral Res; 2016 Sep; 133():62-72. PubMed ID: 27478032
[TBL] [Abstract][Full Text] [Related]
40. Current progress in antiviral strategies.
Lou Z; Sun Y; Rao Z
Trends Pharmacol Sci; 2014 Feb; 35(2):86-102. PubMed ID: 24439476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
